Enhancing the Interferon Pathway to Attack Cancer

• Why is enhancing the interferon pathway an attractive approach for treating cancer?
• What are the novel therapeutic approaches being investigated to harness the innate immune system to enhance the interferon pathway to treat cancer?
• What are the translational approaches being applied to better study therapeutics that activate the interferon pathway against hematologic and solid tumors and identify the patients who may respond better to these therapeutics?

Christine Ward, PhD, Head, oncology Precision and Translational Medicine, Takeda Pharmaceuticals

Learn more about the IO360° Summit at www.io360summit.com